Eric Floyd - 18 May 2022 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
18 May 2022
Net transactions value
+$6,107
Form type
4
Filing time
20 May 2022, 18:12:46 UTC
Previous filing
05 Jan 2022
Next filing
04 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRPX Common Stock, $0.00001 par value Purchase $6,107 +4,479 +127% $1.36 8,018 18 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.